| |
| |
|
| Insider
Information: |
Venkataraman Ganesh |
| Relationship: |
COO & CSO |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
495,145 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$25,985,210 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
495,145 |
|
|
| Total
Value |
$25,985,210 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Momenta Pharmaceuticals Inc |
MNTA |
COO & CSO |
2018-08-21 |
495,145 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
173 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2015-08-20 |
4 |
AS |
$22.20 |
$5,062 |
D/D |
(228) |
387,945 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2015-08-19 |
4 |
AS |
$22.00 |
$8,712 |
D/D |
(396) |
388,173 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2015-08-17 |
4 |
AS |
$21.67 |
$4,681 |
D/D |
(216) |
388,569 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2015-05-20 |
4 |
AS |
$19.68 |
$4,467 |
D/D |
(227) |
388,785 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2015-05-19 |
4 |
AS |
$19.63 |
$7,970 |
D/D |
(406) |
389,012 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2015-05-15 |
4 |
AS |
$19.96 |
$4,291 |
D/D |
(215) |
389,418 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2015-04-23 |
4 |
AS |
$19.95 |
$678,300 |
D/D |
(34,000) |
389,633 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2013-11-25 |
4 |
AS |
$17.77 |
$598,409 |
D/D |
(33,211) |
391,129 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2014-11-25 |
4 |
AS |
$11.67 |
$2,462 |
D/D |
(211) |
393,125 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2014-11-20 |
4 |
AS |
$11.13 |
$2,538 |
D/D |
(228) |
393,336 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2014-11-17 |
4 |
AS |
$10.64 |
$2,309 |
D/D |
(217) |
393,564 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2014-08-25 |
4 |
AS |
$11.45 |
$2,416 |
D/D |
(211) |
393,781 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2014-08-20 |
4 |
AS |
$11.54 |
$2,631 |
D/D |
(228) |
393,992 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2014-08-15 |
4 |
AS |
$11.75 |
$2,550 |
D/D |
(217) |
394,220 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2014-05-23 |
4 |
AS |
$12.09 |
$2,551 |
D/D |
(211) |
394,437 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2014-05-20 |
4 |
AS |
$12.08 |
$2,742 |
D/D |
(227) |
394,648 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2014-05-15 |
4 |
AS |
$11.09 |
$2,407 |
D/D |
(217) |
394,875 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2014-03-21 |
4 |
OE |
$4.91 |
$153,192 |
D/D |
31,200 |
395,092 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2011-11-28 |
4 |
AS |
$14.97 |
$2,725 |
D/D |
(182) |
401,906 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2010-07-23 |
4 |
AS |
$21.38 |
$855,200 |
D/D |
(40,000) |
401,990 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2011-11-23 |
4 |
AS |
$14.97 |
$1,542 |
D/D |
(103) |
402,088 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2011-08-26 |
4 |
AS |
$16.07 |
$2,941 |
D/D |
(183) |
402,403 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2011-11-21 |
4 |
AS |
$15.01 |
$3,182 |
D/D |
(212) |
402,403 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2011-08-23 |
4 |
AS |
$15.58 |
$1,589 |
D/D |
(102) |
402,586 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2011-08-19 |
4 |
AS |
$15.67 |
$3,338 |
D/D |
(213) |
402,688 |
0 |
- |
|
173 Records found
|
|
Page 2 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
